Spread the love

Stephen Garrett Marcus, M..D., received his medical degree from New York Medical College and completed a medical oncology fellowship at the University of California in San Francisco. As a senior research executive in the biotechnology and pharmaceutical industry since 1985, he played a lead role in developing Betaseron as the first effective treatment of multiple sclerosis, and has led multinational research teams for other treatments. Marcus is the president and CEO of a biotechnology company developing new treatments for cancer and other life-threatening illnesses. – www.complicationsofcancer.com

Now listen to all our XZBN shows, with our compliments go to: https://www.spreaker.com/user/xzoneradiotv or www.xzoneuniverse.com